07:34 AM EDT, 08/06/2025 (MT Newswires) -- Aurora Cannabis ( ACB ) , up 1.8% in pre-market trading, on Wednesday said it swung to a first-quarter loss even as revenue rose.

The company reported a loss of $20 million, compared with net income of $3.8 million the year before. Aurora did not provide per share amounts. The net loss was due to a $15 million drop in gross profit, higher operating expenses of $4.3 million and a decrease in other income of $6 million.

Total net revenue rose 17% to $98 million, mainly due to 37% growth in the global medical cannabis business and 4% growth in the plant propagation business. Analysts polled by FactSet had forecast $96.34 million.

Aurora expects to see consolidated net revenue increase in its second quarter, driven primarily by 8% to 12% growth in the global medical cannabis segment.

"Global medical cannabis net revenue (was) supported by 85% growth in international markets, most notably Germany and Poland, alongside growth in Canadian medical cannabis and record contributions from our plant propagation business," said Chief Executive Officer Miguel Martin.

Aurora shares are up US$0.08 to US$4.68, in New York trading.